WZU-13 is a carboxylesterase (CES) inhibitor that inhibits 77% of CES activity at a dose of 100 μM. WZU-13 was discovered primarily through fluorescence-based high-throughput screening and serves as a candidate therapeutic molecule for CES overexpression-related pathological processes, providing a new approach for the diagnosis and treatment of CES-associated metabolic diseases.
Marketplace OffersShowing from 6 suppliers
Supplier
TargetMolSC
Pack Size
Estimated Lead Time
1-3 days
Purity
99.91%
$ 42.00
1
Supplier
ChemDivSC
Pack Size
Estimated Lead Time
3-5 weeks
Purity
-
$ 148.00
1
Supplier
Vitas-MSC
Pack Size
Estimated Lead Time
4-6 weeks
Purity
-
$ 84.31
1
Supplier
ChembridgeSC
Pack Size
Estimated Lead Time
3-4 weeks
Purity
-
$ 60.56
1
Supplier
SpecsSC
Pack Size
Estimated Lead Time
2-3 weeks
Purity
-
$ 37.00
1
Supplier
Princeton BioMolecal ResearchSC
Pack Size
Estimated Lead Time
4-6 weeks
Purity
-
Inquiry
1
You cannot determine which compound library is the best fit for your project? Do you need a custom solution? AnyMol is always ready to help you.